Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial
Melatonin, mitochondria and hypertension [PMID: 28791422] Laboratory literature summary: Melatonin, mitochondria and hypertension
PF-06882961 demonstrates a balanced in vitro signaling profile, potentiates glucose-stimulated insulin release, and decreases food intake in monkeys, and is orally available in healthy human participants
Krog-Mikkelsen I, Hels O, Tetens I, et al
US$ 24.97
US$ 27.15
US$ 26.87
US$ 25.13
US$ 20.08
